|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,055,585 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$64,994,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NGSX |
Neurogesx Inc |
Director |
|
2008-12-10 |
4 |
B |
$1.67 |
$335 |
D/D |
200 |
33,022 |
2.31 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-05 |
4 |
S |
$25.64 |
$5,128 |
D/D |
(200) |
87,993 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-03-31 |
4 |
A |
$72.47 |
$14,494 |
D/D |
200 |
591 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-08-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
377,484 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
200 |
247,333 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-02-07 |
4 |
GA |
$0.00 |
$0 |
I/I |
200 |
100 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-06-30 |
4 |
A |
$103.97 |
$21,626 |
D/D |
208 |
9,190 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2018-09-28 |
4 |
A |
$69.08 |
$14,438 |
D/D |
209 |
5,668 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2018-06-29 |
4 |
A |
$67.00 |
$14,472 |
D/D |
216 |
5,459 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-09-30 |
4 |
A |
$74.23 |
$16,256 |
D/D |
219 |
7,274 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2018-12-31 |
4 |
A |
$63.59 |
$14,499 |
D/D |
228 |
6,896 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-03-31 |
4 |
A |
$73.23 |
$17,282 |
D/D |
236 |
7,700 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-09-30 |
4 |
A |
$89.74 |
$22,794 |
D/D |
254 |
9,444 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-12-31 |
4 |
A |
$86.98 |
$23,920 |
D/D |
275 |
8,921 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-27 |
4 |
S |
$28.00 |
$8,120 |
D/D |
(290) |
129,803 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2017-04-28 |
4 |
A |
$70.30 |
$21,232 |
D/D |
302 |
238,496 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2018-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
290,600 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
326,520 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2023-04-28 |
4 |
A |
$66.88 |
$21,201 |
D/D |
317 |
426,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2020-04-30 |
4 |
A |
$62.59 |
$21,217 |
D/D |
339 |
298,552 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-04-30 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
303,839 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2022-04-29 |
4 |
A |
$62.41 |
$21,281 |
D/D |
341 |
335,324 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2019-08-02 |
4 |
S |
$84.73 |
$31,943 |
D/D |
(377) |
7,055 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-12-09 |
4 |
B |
$1.60 |
$698 |
D/D |
400 |
32,822 |
2.31 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-10 |
4 |
S |
$25.87 |
$10,346 |
D/D |
(400) |
87,593 |
0 |
- |
|
852 Records found
|
|
Page 2 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|